Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 0 | 0 | 6,254 | 0 |
| Gross Profit | N/A | N/A | N/A | 6,254 | N/A |
| Operating Expenses | 24,573 | 23,162 | 62,889 | 25,129 | 23,666 |
| Operating Income | -24,573 | -23,162 | -62,889 | -18,875 | -23,666 |
| Other Income | 112 | 71 | 101 | 72 | 71 |
| Pre-tax Income | -24,461 | -23,091 | -62,788 | -18,803 | -23,595 |
| Net Income Continuous | -24,461 | -23,091 | -60,257 | -18,803 | -23,595 |
| Net Income | $-24,461 | $-23,091 | $-60,257 | $-18,803 | $-23,595 |
| EPS Basic Total Ops | -6.12 | -5.76 | -16.21 | -4.92 | -6.60 |
| EPS Basic Continuous Ops | -6.08 | -5.76 | -16.23 | -4.95 | -6.61 |
| EPS Diluted Total Ops | -6.12 | -5.76 | -16.21 | -4.92 | -6.60 |
| EPS Diluted Continuous Ops | -6.08 | -5.76 | -16.23 | -4.95 | -6.61 |
| EBITDA(a) | $-24,388 | $-22,893 | $-20,943 | $-18,607 | $-23,389 |